153 related articles for article (PubMed ID: 9344699)
21. A novel ELISA for the assessment of classical pathway of complement activation in vivo by measurement of C4-C3 complexes.
Zwirner J; Dobos G; Götze O
J Immunol Methods; 1995 Oct; 186(1):55-63. PubMed ID: 7561148
[TBL] [Abstract][Full Text] [Related]
22. Complement activation in patients with systemic lupus erythematosus without nephritis.
Mollnes TE; Haga HJ; Brun JG; Nielsen EW; Sjöholm A; Sturfeldt G; Mårtensson U; Bergh K; Rekvig OP
Rheumatology (Oxford); 1999 Oct; 38(10):933-40. PubMed ID: 10534542
[TBL] [Abstract][Full Text] [Related]
23. Complement activation products in idiopathic pulmonary fibrosis: relevance of fragment Ba to disease severity.
Meliconi R; Senaldi G; Sturani C; Galavotti V; Facchini A; Gasbarrini G; Vergani D
Clin Immunol Immunopathol; 1990 Oct; 57(1):64-73. PubMed ID: 2394036
[TBL] [Abstract][Full Text] [Related]
24. SC5b-9 is the most sensitive marker in assessing disease activity in Brazilian SLE patients.
Chiu YY; Nisihara RM; Würzner R; Kirschfink M; de Messias-Reason IJ
J Investig Allergol Clin Immunol; 1998; 8(4):239-44. PubMed ID: 9777539
[TBL] [Abstract][Full Text] [Related]
25. Studies on protein adsorption and activation of complement on hydrated aluminium surfaces in vitro.
Tengvall P; Askendal A; Lundström I
Biomaterials; 1998 May; 19(10):935-40. PubMed ID: 9690835
[TBL] [Abstract][Full Text] [Related]
26. Complement activation during painful crisis in sickle cell anemia.
Mold C; Tamerius JD; Phillips G
Clin Immunol Immunopathol; 1995 Sep; 76(3 Pt 1):314-20. PubMed ID: 7554454
[TBL] [Abstract][Full Text] [Related]
27. Complement components and their activation products in pleural fluid.
Salomaa ER; Viander M; Saaresranta T; Terho EO
Chest; 1998 Sep; 114(3):723-30. PubMed ID: 9743157
[TBL] [Abstract][Full Text] [Related]
28. Activation of the complement system in systemic sclerosis. Relationship to clinical severity.
Senaldi G; Lupoli S; Vergani D; Black CM
Arthritis Rheum; 1989 Oct; 32(10):1262-7. PubMed ID: 2803327
[TBL] [Abstract][Full Text] [Related]
29. Assessment of disease activity and impending flare in patients with systemic lupus erythematosus. Comparison of the use of complement split products and conventional measurements of complement.
Buyon JP; Tamerius J; Belmont HM; Abramson SB
Arthritis Rheum; 1992 Sep; 35(9):1028-37. PubMed ID: 1418018
[TBL] [Abstract][Full Text] [Related]
30. Classical complement activation induced by pregnancy: implications for management of connective tissue diseases.
Hopkinson ND; Powell RJ
J Clin Pathol; 1992 Jan; 45(1):66-7. PubMed ID: 1740520
[TBL] [Abstract][Full Text] [Related]
31. Levels of complement components iC3b, C3c, C4, and SC5b-9 in peritoneal fluid and serum of infertile women with endometriosis.
Kabut J; Kondera-Anasz Z; Sikora J; Mielczarek-Palacz A
Fertil Steril; 2007 Nov; 88(5):1298-303. PubMed ID: 17482181
[TBL] [Abstract][Full Text] [Related]
32. Complement activation products in plasma after heart transplantation in humans.
Vallhonrat H; Williams WW; Dec GW; Keck S; Schoenfeld D; Cosimi AB; Pascual M
Transplantation; 2001 May; 71(9):1308-11. PubMed ID: 11397968
[TBL] [Abstract][Full Text] [Related]
33. Activation of the complement system in human immunodeficiency virus infection: relevance of the classical pathway to pathogenesis and disease severity.
Senaldi G; Peakman M; McManus T; Davies ET; Tee DE; Vergani D
J Infect Dis; 1990 Dec; 162(6):1227-32. PubMed ID: 1977807
[TBL] [Abstract][Full Text] [Related]
34. Different patterns of C3 and C4 activation in the varied types of juvenile arthritis.
Miller JJ; Olds LC; Silverman ED; Milgrom H; Curd JG
Pediatr Res; 1986 Dec; 20(12):1332-7. PubMed ID: 3099253
[TBL] [Abstract][Full Text] [Related]
35. [In-vivo activation of the 4th component of the complement system (C4) in premature and term infants with generalized bacterial infections].
Nürnberger W; Stannigel H; Müntel V; Michelmann I; Wahn V; Göbel U
Klin Padiatr; 1990; 202(3):141-6. PubMed ID: 2355716
[TBL] [Abstract][Full Text] [Related]
36. Complement activation in cancer patients undergoing immunotherapy with interleukin-2 (IL-2): binding of complement and C-reactive protein by IL-2-activated lymphocytes.
Vachino G; Gelfand JA; Atkins MB; Tamerius JD; Demchak P; Mier JW
Blood; 1991 Nov; 78(10):2505-13. PubMed ID: 1824247
[TBL] [Abstract][Full Text] [Related]
37. Development and application of an enzyme-linked immunosorbent assay for the quantitation of alternative complement pathway activation in human serum.
Mayes JT; Schreiber RD; Cooper NR
J Clin Invest; 1984 Jan; 73(1):160-70. PubMed ID: 6418767
[TBL] [Abstract][Full Text] [Related]
38. Assessment of the activation pathways of the complement in psoriatic patients by use of complement fragment C4d and Bb measurements.
Takematsu H; Tagami H
Dermatologica; 1989; 179 Suppl 1():16-9. PubMed ID: 2789155
[TBL] [Abstract][Full Text] [Related]
39. Complement activation in platelet concentrates is surface-dependent and modulated by the platelets.
Gyongyossy-Issa MI; McLeod E; Devine DV
J Lab Clin Med; 1994 Jun; 123(6):859-68. PubMed ID: 8201264
[TBL] [Abstract][Full Text] [Related]
40. Activation of the classical complement pathway in spontaneous bacterial peritonitis.
Bird G; Senaldi G; Panos M; Rolando N; Alexander G; Vergani D; Williams R
Gut; 1992 Mar; 33(3):307-11. PubMed ID: 1568647
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
